Paul, LaViolette
Paul LaViolette is Managing Partner & COO at SV Health Investors. He brings over 34 years of global medical technology management experience. Paul was most recently Chief Operating Officer at – …
Earl (Duke), Collier
Duke Collier served from 2010-2014 as the Chief Executive Officer of 480 Biomedical, a medical device company developing products used in the treatment of peripheral artery disease, and the executive – …
Joe, Cunningham, MD
Joe Cunningham is a Founding Partner and Managing Director of Santé Ventures, an early stage life science and healthcare venture capital company based in Austin and Houston, Texas. Prior to – …
Jean-François, Formela, MD
Jean-François Formela focuses on new advances in biology and drug discovery technologies as well as novel therapeutics. He is chair of the board of IFM Therapeutics and KDAC Therapeutics, and – …
Michael, Greeley
Michael is a General Partner at Flare Capital Mass General Brigham. Prior to co-founding Flare Capital Mass General Brigham, Michael was the founding General Partner of Flybridge Capital Mass General – …
Adele, Gulfo
Adele Gulfo is the Chief of Commercial Development, Roivant Sciences. Previously, she served as Chief Strategy Officer, EVP and Head of Global Commercial Development at Mylan. She is currently a – …
Reid, Huber, PhD
Dr. Huber joined Third Rock Ventures in 2018 as Partner. Third Rock is one of the industries preeminent life sciences company creation firms based in Boston, MA. At Third Rock, – …
Andy, Hurd
Andy Hurd is an Operating Partner at Cressey and Company, previously serving as Chief Executive Officer of Mede Analytics, bringing with him over 25 years of experience in healthcare IT, – …
Keith, Kerman, MD
Keith Kerman, MD is an Operating Partner and Senior Advisor with The Riverside Company, a global private equity firm focused on growth businesses. Dr. Kerman has 20 years of experience – …
Adam, Koppel, MD, PhD
Adam Koppel rejoined Bain Capital in 2016 as Managing Director of the Bain Capital Life Sciences Fund. He had initially joined Bain Capital Public Equity in 2003 where he was – …
John, Lepore, MD
John Lepore is SVP for R&D Pipeline at GlaxoSmithKline, where his group is responsible for R&D activities across neuroscience, rare diseases, respiratory, and metabolic and cardiovascular disease. His group is – …
Barbara, Lubash
Barbara Lubash is a Director and Advisor for corporate and non-profit boards. She serves on the boards of Advanced ICU Care, CareConnectMD, Clew Medical, and the Solve ME/CFS (Chronic Fatigue – …
